Johnson & Johnson: Dividend Hike Ahead

Johnson & Johnson (NYSE:JNJ) has incurred a 12% correction during the last two months. Nevertheless, most of its shareholders have a long-term perspective and thus hold the stock for its reliable and growing dividend. Therefore, as the company is expected to raise its dividend next month, the big question is what dividend hike its shareholders should be expecting.

Business overview

While most consumers know this stalwart for its consumer products, the company generates essentially half of its sales from its pharmaceutical segment. In addition, this segment is the one that is growing faster at the moment whereas the consumer segment is facing some secular challenges.

READ FULL ARTICLE HERE